Sagittarius Life Science Corp (3205.TWO) engages in the research, development, production, and sale of Chinese and western medicines, health food products, organic food, daily necessities, and pet food in Taiwan and Asia. The company specializes in biotechnology research with a focus on plant-derived new drugs, nutrition and health care products, skin care products, and immune adjustment, beauty, anti-aging, and antioxidant supplements; it also provides technical services for biochemical product development, customized formulation design, and contract manufacturing of patented products. Founded in 1998 and headquartered at 10F-6, No. 3, Yuanqu Street, Nangang District, Taipei, Taiwan, Sagittarius Life Science operates primarily in the healthcare and biotechnology sectors, targeting consumer health markets through self-branded sales and professional distribution networks across domestic and regional channels. Recent financial reports indicate ongoing revenue from core operations amid market challenges, with 2025 year-to-date sales at approximately NT$3.23 billion as of October, reflecting year-over-year declines but sustained R&D efforts in natural herbal extracts and clinical-stage botanical pharmaceuticals undergoing Phase II trials in Taiwan and China.